# Pharmacokinetic Study to Characterize Phenotyping Metrics of the "Basel" Cocktail After CYP Induction or Inhibition

> **NCT01386593** · PHASE1 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 16 (actual)

## Conditions studied

- Metabolic Detoxication, Phase I

## Interventions

- **DRUG:** Basel cocktail+(Fluconazole, Ciprofloxacin, Paroxetine)
- **DRUG:** "Basel" Cocktail
- **DRUG:** Basel cocktail + Rifampicin

## Key facts

- **NCT ID:** NCT01386593
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386593, "Pharmacokinetic Study to Characterize Phenotyping Metrics of the "Basel" Cocktail After CYP Induction or Inhibition". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT01386593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*